Metropolitan Life Insurance CO Humacyte, Inc. Transaction History

Metropolitan Life Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.57 - $4.84 $475 - $895	185 Added 14.25%	1,483 $4,000
Q4 2023 Feb 14, 2024	SELL	$1.99 - $3.12 $4,525 - $7,094	-2,274 Reduced 63.66%	1,298 $3,000
Q1 2023 May 15, 2023	SELL	$2.11 - $3.25 $1,154 - $1,777	-547 Reduced 13.28%	3,572 $11,000
Q4 2022 Jun 14, 2023	BUY	$2.02 - $3.62 $1,104 - $1,980	547 Added 15.31%	4,119 $8.69 Million
Q4 2022 Feb 15, 2023	BUY	$2.02 - $3.62 $8,320 - $14,910	4,119 New	4,119 $8,000

172

41M

553K

942K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $365M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.